Johnson & Johnson (NYSE: JNJ) announced today that it would name one of its two companies, a consumer health company ahead of its spin-off as Kenvue.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The company stated that “Kenvue (pronounced ken·view), is inspired by two powerful ideas: “ken” – meaning knowledge, an English word primarily used in Scotland, and “vue,” referencing sight.”
Is J&J a Good Stock to Buy?
Wall Street analysts are cautiously optimistic about the stock with a Moderate Buy consensus rating based on six Buys and four Holds.
The average price forecast for JNJ stock is $188.33 implying an upside potential of 13%.
